Works matching AU Le Malicot, K.

Results: 3
    1

    Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 3, p. 577, doi. 10.1007/s10120-018-0885-z
    By:
    • Touchefeu, Y.;
    • Guimbaud, R.;
    • Louvet, C.;
    • Dahan, L.;
    • Samalin, E.;
    • Barbier, E.;
    • Le Malicot, K.;
    • Cohen, R.;
    • Gornet, J. M.;
    • Aparicio, T.;
    • Nguyen, S.;
    • Azzedine, A.;
    • Etienne, P. L.;
    • Phelip, J. M.;
    • Hammel, P.;
    • Chapelle, N.;
    • Sefrioui, D.;
    • Mineur, L.;
    • Lepage, C.;
    • Bouche, O.
    Publication type:
    Article
    2

    Loss of SMARCB1 expression in colon carcinoma.

    Published in:
    Cancer Biomarkers, 2020, v. 27, n. 3, p. 399, doi. 10.3233/CBM-190287
    By:
    • Melloul, S.;
    • Mosnier, J.-F.;
    • Masliah-Planchon, J.;
    • Lepage, C.;
    • Le Malicot, K.;
    • Gornet, J.-M.;
    • Edeline, J.;
    • Dansette, D.;
    • Texereau, P.;
    • Delattre, O.;
    • Laurent Puig, P.;
    • Taieb, J.;
    • Emile, J.-F.
    Publication type:
    Article
    3

    Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 11, p. 3561, doi. 10.1245/s10434-019-07513-6
    By:
    • Bruzzi, M.;
    • Auclin, E.;
    • Lo Dico, R.;
    • Voron, T.;
    • Karoui, M.;
    • Espin, E.;
    • Cianchi, F.;
    • Weitz, J.;
    • Buggenhout, A.;
    • Malafosse, R.;
    • Denimal, F.;
    • Le Malicot, K.;
    • Vernerey, D.;
    • Douard, R.;
    • Emile, J. F.;
    • Lepage, C.;
    • Laurent-Puig, P.;
    • Taieb, J.
    Publication type:
    Article